Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 19 min ago
Peer-reviewedCC BY 4.0Frontiers in Neuroscience

Modifiable glymphatic-related brain clearance physiology in humans: a critical narrative review of interventional evidence

5 affiliations
  1. 1Medical University of Warsaw
  2. 2Department of Neurosurgery
  3. 3Department of Didactics and Medical Simulation, Medical University of Lublin
  4. 4Anesthesiology Department, The First Affiliated Hospital of Ningbo University
  5. 5Gamma Knife Center

Abstract

The glymphatic model proposes that cerebrospinal fluid exchanges with interstitial fluid along perivascular pathways, potentially facilitating brain solute clearance. Interest in whether this physiology can be modified has prompted human studies of sleep, exercise, respiratory manipulation, circadian interventions, and neuromodulation, but these studies use endpoints that differ substantially in biological directness. This critical narrative review evaluates human interventional and longitudinal evidence for modifiable glymphatic-related brain-clearance physiology and distinguishes altered neurofluid dynamics from evidence of solute transport. Sleep provides the most convincing convergent evidence: total sleep deprivation impairs intrathecal tracer clearance, whereas normal sleep increases the overnight appearance of amyloid-β and tau in plasma. Sustained aerobic exercise modifies contrast-based brain influx and meningeal lymphatic measures, although evidence remains preliminary. Slow deep breathing and intermittent hypercapnia alter cerebrospinal fluid dynamics; hypercapnia also increases several plasma brain-protein concentrations, but enhanced clearance is unconfirmed. Bright light therapy and transcranial magnetic stimulation modify diffusion-based perivascular imaging proxies that remain indirect and biologically nonspecific. Human neurofluid physiology may therefore be modifiable, but changes in fluid motion or surrogate imaging signals should not be equated with enhanced solute clearance. Clinically meaningful modulation will require controlled studies linking mechanistic target engagement to direct solute transport and neurological outcomes.

Related

  1. Noninvasive ultrashort wave neuromodulation enhances glymphatic clearance to alleviate traumatic brain edema and Alzheimer’s pathology
    Jinwei Liu, Chuang Xu, Huaqiang Ruan +15
    Science AdvancesPeer-reviewedCC BY-NCFull textNeuroscienceCrossrefEurope PMC
  2. Multimodal evidence for impaired glymphatic brain clearance as a mediator of "inflammaging" in schizophrenia - integrating insights from in vivo neuroimaging, omics, and post-mortem single nucleus-RNA-Seq data
    X. Tan, M. Simon, D. Rosebrock +10
    bioRxivPreprintCC BYFull textNeurosciencebioRxiv
  3. Glymphatic System Is Enhanced in Anti-NMDAR Encephalitis and Facilitates Antibody Influx and Clearance in the Brain
    D. Wang, J. Liu, F. He +7
    bioRxivPreprintCC BY-NCFull textNeurosciencebioRxiv
  4. Glymphatic system impairment in neurological disorders: potential mechanisms and therapeutic targets
    Nannan Wang, Z.H. Liu, Yong Wang +2
    Molecular BiomedicinePeer-reviewedCC BYFull text5 citedNeuroscienceOpenAlex
  5. MRI-derived glymphatic-related composite captures brain and cognitive vulnerability associated with cardiovascular risk in older adults.
    Zhan Wang, Guojun Lin, Fang Fang +1
    Alzheimer's & dementia : the journal of the Alzheimer's AssociationPeer-reviewedCC BY-NC-NDFull textNeuroscienceEurope PMCPMC
BibTeX
@article{wrzesien2026modifiable,
  title = {{Modifiable glymphatic-related brain clearance physiology in humans: a critical narrative review of interventional evidence}},
  author = {Marta M. Wrzesień and Kamil Pobozy and Grzegorz Turek and Wojciech Czyzewski and Binbin Zhu and Mirosław Ząbek},
  journal = {Frontiers in Neuroscience},
  year = {2026},
  month = oct,
  doi = {10.3389/fnins.2026.1984401},
  url = {https://www.frontiersin.org/articles/10.3389/fnins.2026.1984401/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Modifiable glymphatic-related brain clearance physiology in humans: a critical narrative review of interventional evidence
AU  - Marta M. Wrzesień
AU  - Kamil Pobozy
AU  - Grzegorz Turek
AU  - Wojciech Czyzewski
AU  - Binbin Zhu
AU  - Mirosław Ząbek
PY  - 2026
DA  - 2026/10/09
JO  - Frontiers in Neuroscience
DO  - 10.3389/fnins.2026.1984401
UR  - https://www.frontiersin.org/articles/10.3389/fnins.2026.1984401/full
AB  - The glymphatic model proposes that cerebrospinal fluid exchanges with interstitial fluid along perivascular pathways, potentially facilitating brain solute clearance. Interest in whether this physiology can be modified has prompted human studies of sleep, exercise, respiratory manipulation, circadian interventions, and neuromodulation, but these studies use endpoints that differ substantially in biological directness. This critical narrative review evaluates human interventional and longitudinal evidence for modifiable glymphatic-related brain-clearance physiology and distinguishes altered neurofluid dynamics from evidence of solute transport. Sleep provides the most convincing convergent evidence: total sleep deprivation impairs intrathecal tracer clearance, whereas normal sleep increases the overnight appearance of amyloid-β and tau in plasma. Sustained aerobic exercise modifies contrast-based brain influx and meningeal lymphatic measures, although evidence remains preliminary. Slow deep breathing and intermittent hypercapnia alter cerebrospinal fluid dynamics; hypercapnia also increases several plasma brain-protein concentrations, but enhanced clearance is unconfirmed. Bright light therapy and transcranial magnetic stimulation modify diffusion-based perivascular imaging proxies that remain indirect and biologically nonspecific. Human neurofluid physiology may therefore be modifiable, but changes in fluid motion or surrogate imaging signals should not be equated with enhanced solute clearance. Clinically meaningful modulation will require controlled studies linking mechanistic target engagement to direct solute transport and neurological outcomes.
SN  - 1662-453X
SN  - 1662-4548
ER  -